Finance & Acquisitions: Catalent

Parents

2007: The New York private equity firm Blackstone Group bought the business from Cardinal Health in 2007 for a reported $3.3 billion
2011: Catalent Pharma Solutions to Acquire Aptuit LLCs (2011)
2014: New Jersey biotech company Catalent files for IPO _medcitynews
2016: Catalent Signed Agreement to Acquire Pharmatek Laboratories
2018: Catalent to acquire Boston's Juniper Pharmaceuticals for $128M_www.bizjournals.com
2018: JNP acquired by Catalent +32% • BioPharmCatalyst
2019: Ahead of US gene therapy explosion, big contract drug manufacturer Catalent makes $1.2 billion bet on Paragon Bioservices – Endpoints News
2019: Beefing up its new gene therapy unit, Catalent inks $18M deal to snap up Novavax facilities – Endpoints News
2021: Catalent Has Acquired Delphi Genetics and Launches US Plasmid Site_Plasmid DNA
2022: Catalent, Inc. 2023 Q1 - Results - Earnings Call Presentation- seekingalpha.com
2023: FY 2023 Revenues: $4.276 billion
2024: Novo Nordisk buys manufacturing power as it seeks to ramp up Wegovy_Catalent Inc.
Aptuit, LLC
Catalent, which makes drug delivery technologies for major pharmaceutical companies, is owned by The Blackstone Group
Delphi Genetics
Juniper Pharmaceuticals, Inc. (Nasdaq: JNP)
Paragon Bioservices
Pharmatek Laboratories
Revenue: 3.998 billion USD (Fiscal Year Ended June 30, 2021)